Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Synergistic Effects of Tranylcypromine and NRF2 Inhibitor: A Repurposing Strategy for Effective Cancer Therapy

View through CrossRef
AbstractDrug repurposing has emerged as an attractive strategy for accelerating drug discovery for cancer treatment. In this study, we investigated combining Tranylcypromine (TCP) with a number of well‐characterized drugs. Among these combinations, NRF2 inhibitor (ML385) exhibited synergistic effects in combination with TCP. Specifically, our results showed that the combination of TCP and ML385 resulted in a significant reduction in tumor proliferation while neither drug affected cancer cell growth meaningfully on its own. While further studies are needed to understand fully the extent of the synergistic efficacy, the underlying respective mechanisms and the potential side effects of this approach, our study has yielded a promising start for the development of an effective combination cancer therapy.
Title: Synergistic Effects of Tranylcypromine and NRF2 Inhibitor: A Repurposing Strategy for Effective Cancer Therapy
Description:
AbstractDrug repurposing has emerged as an attractive strategy for accelerating drug discovery for cancer treatment.
In this study, we investigated combining Tranylcypromine (TCP) with a number of well‐characterized drugs.
Among these combinations, NRF2 inhibitor (ML385) exhibited synergistic effects in combination with TCP.
Specifically, our results showed that the combination of TCP and ML385 resulted in a significant reduction in tumor proliferation while neither drug affected cancer cell growth meaningfully on its own.
While further studies are needed to understand fully the extent of the synergistic efficacy, the underlying respective mechanisms and the potential side effects of this approach, our study has yielded a promising start for the development of an effective combination cancer therapy.

Related Results

A Stress-Responsive Transcriptional Factor NRF2 Activates Hematopoietic Stem Cells
A Stress-Responsive Transcriptional Factor NRF2 Activates Hematopoietic Stem Cells
Abstract KEAP1-NRF2 system is a major regulator of cellular redox balance and xenobiotic metabolism. NRF2 is an inducible transcription factor, and KEAP1 is its nega...
Combination of Tranylcypromine and Mirtazapine in Difficult-to-Treat Depression
Combination of Tranylcypromine and Mirtazapine in Difficult-to-Treat Depression
Abstract Background About one third of depression patients do not respond to the first antidepressant trial. Difficult-to-treat depression was su...
Abstract 391: Role of NRF2 in HIF-2α-mediated cancer stem cell phenotype
Abstract 391: Role of NRF2 in HIF-2α-mediated cancer stem cell phenotype
Abstract The acquisition of cancer stem cell (CSC) properties is influenced by the microenvironment, with tumor hypoxia playing a pivotal role. Elevated levels of nu...
Abstract 1702: Loss of KEAP1 promotes R-loop formation independent of NRF2
Abstract 1702: Loss of KEAP1 promotes R-loop formation independent of NRF2
Abstract This study investigates the mechanism of R-loop formation as a consequence of KEAP1 depletion. R-loops, described as three-stranded nucleic acid structures ...

Back to Top